title: Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy.
authors.affiliation: University of Toronto, Ontario, Canada.
authors.forename: M A
authors.initials: MA
authors.lastname: Flowers
authors.forename: J
authors.initials: J
authors.lastname: Heathcote
authors.forename: I R
authors.initials: IR
authors.lastname: Wanless
authors.forename: M
authors.initials: M
authors.lastname: Sherman
authors.forename: W J
authors.initials: WJ
authors.lastname: Reynolds
authors.forename: R G
authors.initials: RG
authors.lastname: Cameron
authors.forename: G A
authors.initials: GA
authors.lastname: Levy
authors.forename: R D
authors.initials: RD
authors.lastname: Inman
mesh_terms: D002353:Carrier State / Q000276:immunology*; D005260:Female; D006509:Hepatitis B / Q000209:etiology* / Q000276:immunology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000254:growth & development; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D013375:Substance Withdrawal Syndrome / Q000276:immunology / Q000382:microbiology*; D014775:Virus Activation / Q000187:drug effects* / Q000276:immunology
chemical_list: D008727:Methotrexate